Premier (NASDAQ:PINC) Releases FY 2025 Earnings Guidance

Premier (NASDAQ:PINC) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.260-1.340 for the period, compared to the consensus estimate of 1.290. The company issued revenue guidance of $940.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.8 million.

Premier Price Performance

Shares of NASDAQ PINC traded down $2.51 during mid-day trading on Tuesday, hitting $19.89. 517,385 shares of the stock traded hands, compared to its average volume of 1,132,590. The company has a market cap of $1.91 billion, a PE ratio of 14.69 and a beta of 0.43. Premier has a twelve month low of $17.95 and a twelve month high of $23.56. The firm has a 50 day simple moving average of $21.91 and a two-hundred day simple moving average of $20.96.

Premier (NASDAQ:PINC) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.04). Premier had a net margin of 11.41% and a return on equity of 10.74%. On average, equities research analysts anticipate that Premier will post 1.12 earnings per share for the current fiscal year.

Premier Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Saturday, March 15th. Investors of record on Saturday, March 1st will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 4.22%. The ex-dividend date of this dividend is Friday, February 28th. Premier’s payout ratio is presently 61.77%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PINC. StockNews.com downgraded shares of Premier from a “buy” rating to a “hold” rating in a research report on Tuesday, November 5th. Barclays boosted their target price on shares of Premier from $20.00 to $24.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. Robert W. Baird lifted their price objective on Premier from $19.00 to $20.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 6th. Finally, Canaccord Genuity Group boosted their price objective on Premier from $19.00 to $21.00 and gave the company a “hold” rating in a research note on Wednesday, November 6th. Ten equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $21.36.

Insiders Place Their Bets

In other Premier news, Director John T. Bigalke sold 1,136 shares of the company’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $22.19, for a total value of $25,207.84. Following the completion of the sale, the director now directly owns 23,846 shares of the company’s stock, valued at approximately $529,142.74. This represents a 4.55 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Michael J. Alkire sold 18,374 shares of the stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $21.80, for a total value of $400,553.20. Following the sale, the chief executive officer now directly owns 502,354 shares of the company’s stock, valued at $10,951,317.20. The trade was a 3.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 59,425 shares of company stock worth $1,320,242. Insiders own 0.96% of the company’s stock.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.